Invesaro

Stocks Consumer discretionary SYRA

OTC · Consumer discretionary

Syra Health Corp (SYRA)

Syra Health Corp brought in $8.1M of revenue over the twelve months to June 30, 2026, up 0.3% from a year earlier. Net income was $130.7K, a net margin of 1.6%. In fiscal 2025 capital spending exceeded operating cash flow by $447.9K. At June 30, 2026 it held $2.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.

Free, no password. An email when SYRA files with the SEC.

Price
$0.80
-0.38% on the day · November 9, 2026
52-week range $0.06 to $1.15
Market cap
$11M
Revenue (last 12 months)
$8.1M
+0.3% year on year
Net margin
1.6%

Key facts about Syra Health Corp

Net worth
Syra Health Corp has a market value (market cap) of $11M at the latest share price, and shareholders' equity of $2.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $7.2M (-9.5% year on year), with a net loss of $896.3K. Over the 12 months to June 30, 2026: revenue $8.1M, net income $130.7K.
Cash flow
In fiscal 2025 operations used $447.7K of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 11, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Syra Health Corp's next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Syra Health Corp does

Syra Health Corp is registered with the SEC under industry code SIC 7361 (Services-Employment Agencies). Its shares trade on OTC under the ticker SYRA.

Revenue and profit by year

Revenue
FY23: $5.6M $5.6M FY23FY23: $5.5M $5.5M FY23FY24: $8M $8M FY24FY25: $7.2M $7.2M FY25
Net income
FY23: -$2.1M -$2.1M FY23FY23: -$2.9M -$2.9M FY23FY24: -$3.8M -$3.8M FY24FY25: -$896.3K -$896.3K FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$7.2M-$904.3K-$896.3K-$0.08-$447.9K
2024$8M-$3.8M-$3.8M-$0.50-$2.9M
2023$5.5M-$2.9M-$2.9M-$0.60-$2.8M
2023$5.6M-$2.1M-$2.1M-$0.70-$2.4M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 11, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 12, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where SYRA ranks in Consumer discretionary

Revenue$7.2M
#950 of 1077 in Consumer discretionary · Bottom 12%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer discretionary

Latest SEC filings

What Syra Health Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 1, 2026
  2. September 29, 2026
  3. September 14, 2026
  4. August 13, 2026
  5. August 11, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 23% to $2.4M versus the same quarter last year; diluted EPS $0.02 versus -$0.01.
  6. August 11, 2026
  7. July 23, 2026
  8. June 1, 2026
  9. June 1, 2026
  10. June 1, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 28, 2026. Insider transactions on SEC

Insider trades

What the people running Syra Health Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
January 5, 2026 Alexander Gregory R.CEO Received as pay 110,537 - - Form 4
January 5, 2026 Alexander Gregory R.CEO Received as pay 110,537 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SYRA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Johnson Neil Lawrence13D, may seek influence 6.2% 700,312 January 16, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 110,537 shares in total, about $88.2K at the last price.

HolderSharesAs of
Alexander Gregory R.CEO 110,537 January 5, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SYRA

What does Syra Health Corp do?

Syra Health Corp is a company in the Consumer discretionary sector, listed on OTC as SYRA. Its shares trade on OTC under the ticker SYRA.

What is Syra Health Corp's net worth?

Syra Health Corp has a market value (market cap) of $11M at the latest share price, and shareholders' equity of $2.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Syra Health Corp profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $130.7K on revenue of $8.1M, a net margin of 1.6%.

How much revenue does Syra Health Corp make?

Over the twelve months to June 30, 2026 Syra Health Corp reported revenue of $8.1M. That is 0.3% more than a year earlier.

When did Syra Health Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the form POS AM filing from October 1, 2026.

When is Syra Health Corp's next earnings report?

Syra Health Corp's next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare SYRA with

Compare SYRA with any company

Follow SYRA

Get an email when Syra Health Corp files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when SYRA files with the SEC.

Where the numbers come from

Financial figures are the values Syra Health Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.